The FDA (Food and Drug Administration)’s CDER (Center for Drug Evaluation and Research has released its guidance calendar for 2021. Many items on the agenda relate to clinical and medical topics, along with points related to generic drugs and clinical pharmacology. Four points relate to RWE (real world evidence) practices. Learn more here.
(Source: FDA.gov, 1/25/2021)